Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States
- PMID: 26003814
- DOI: 10.1007/s00586-015-4032-9
Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States
Erratum in
-
Erratum to: Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States.Eur Spine J. 2015 Sep;24(9):2099. doi: 10.1007/s00586-015-4083-y. Epub 2015 Jun 25. Eur Spine J. 2015. PMID: 26108390 No abstract available.
Abstract
Purpose: A retrospective database review was carried out to evaluate the trends and demographics of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States.
Methods: Patients who underwent single-level PLF from 2005 to 2011 were identified by searching ICD-9 diagnosis and procedure codes in the PearlDiver Patient Records Database (PearlDiver Technologies, Fort Wayne, IN, USA), a national database of orthopaedic insurance records. The year of procedure, age, gender, and region of the United States were recorded for each patient. Results were reported for each variable as the incidence of procedures identified per 100,000 patients searched in the database.
Results: Totally 5158 patients had single-level PLF in this study. The average rate of single-level PLF with rhBMP utilization maintained at a relatively stable level (19.1-23.5%) from 2005 to 2009, but sharply decreased to 6.8% in 2010 and 6.9% in 2011. The overall incidence of single-level PLF without rhBMP (1.37 cases per 100,000 patients) was more than five times of the incidence of single-level PLF with rhBMP (0.27 cases per 100,000 patients) (P < 0.01). The average rate of single-level PLF with rhBMP utilization is highest in Midwest (18.7%), followed by West (18.4%), South (16.4%) and Northeast (11.5%). The highest incidence of single-level PLF with rhBMP was observed in the group aged 70-74 years with an incidence of 0.33 per 100,000 patients.
Conclusions: The incidence of rhBMP utilization in single-level PLF increased from 2006 to 2009, but dropped to a low level in 2010 and 2011. The Northeast region had the lowest incidence of rhBMP utilization. The group aged 70-74 years trended to have the higher incidence of single-level PLF with rhBMP utilization.
Keywords: Demographics; Posterior lumbar fusion; Recombinant human bone morphogenetic protein (rhBMP); Single-level.
Similar articles
-
Trends Analysis of rhBMP Utilization in Single-Level Posterior Lumbar Interbody Fusion in the United States.Global Spine J. 2017 Oct;7(7):624-628. doi: 10.1177/2192568217699387. Epub 2017 Jun 30. Global Spine J. 2017. PMID: 28989840 Free PMC article.
-
Trends in the surgical treatment of lumbar spine disease in the United States.Spine J. 2015 Aug 1;15(8):1719-27. doi: 10.1016/j.spinee.2013.10.014. Epub 2013 Oct 31. Spine J. 2015. PMID: 24184652
-
Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?J Neurosurg Spine. 2017 May;26(5):586-593. doi: 10.3171/2016.10.SPINE16649. Epub 2017 Feb 3. J Neurosurg Spine. 2017. PMID: 28156207
-
Comparison of the use of rhBMP-7 versus iliac crest autograft in single-level lumbar fusion: a meta-analysis of randomized controlled trials.J Bone Miner Metab. 2018 Jan;36(1):119-127. doi: 10.1007/s00774-017-0821-z. Epub 2017 Mar 24. J Bone Miner Metab. 2018. PMID: 28342094
-
Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials.Arch Orthop Trauma Surg. 2012 Dec;132(12):1725-40. doi: 10.1007/s00402-012-1607-3. Epub 2012 Sep 1. Arch Orthop Trauma Surg. 2012. PMID: 22941273
Cited by
-
A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2).J Orthop Surg Res. 2020 Nov 19;15(1):544. doi: 10.1186/s13018-020-02078-7. J Orthop Surg Res. 2020. PMID: 33213484 Free PMC article.
-
Trends, Costs, and Complications of Anterior Cervical Discectomy and Fusion With and Without Bone Morphogenetic Protein in the United States Medicare Population.Global Spine J. 2017 Oct;7(7):603-608. doi: 10.1177/2192568217699207. Epub 2017 Aug 17. Global Spine J. 2017. PMID: 28989837 Free PMC article. Review.
-
Trends Analysis of rhBMP Utilization in Single-Level Posterior Lumbar Interbody Fusion in the United States.Global Spine J. 2017 Oct;7(7):624-628. doi: 10.1177/2192568217699387. Epub 2017 Jun 30. Global Spine J. 2017. PMID: 28989840 Free PMC article.
-
Co-delivery of rhBMP-2 and zoledronic acid using calcium sulfate/hydroxyapatite carrier as a bioactive bone substitute to enhance and accelerate spinal fusion.Bioact Mater. 2024 Mar 6;36:256-271. doi: 10.1016/j.bioactmat.2024.02.034. eCollection 2024 Jun. Bioact Mater. 2024. PMID: 38487704 Free PMC article.
-
Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.Eur Spine J. 2017 Mar;26(3):754-763. doi: 10.1007/s00586-016-4927-0. Epub 2016 Dec 27. Eur Spine J. 2017. PMID: 28028645
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources